If you wish to respond to a paper or other item already published in the BJA, please go to the abstract/full text version of that item and click on the link "E-Letters: Submit a response to the article".
Electronic Letters to:
|
|
E-letters: Electronic letters published:
-
![[Read E-letter]](/icons/misc/sectionDOWN.gif)
Response to the E-letter
- Akifumi Kanai (10 November 2006)
-
Stinging and burning after intranasal lidocaine
- Daniel W Wheeler (19 October 2006)
|
|
|||
|
Akifumi Kanai, MD, PhD Anesthesiology
Send letter to journal:
|
We greatly appreciate the comments by Dr. Wheeler regarding our article on intranasal 8% lidocaine spray. As he described, 0.2ml of 8% lidocaine frequently produces burning, stinging or numbness of the treated nostril, resulting in unpleasantness for patients. In our department, the treatment is not the first-line therapy for trigeminal neuralgia. However, we often apply intranasal lidocaine spray to patients with refractory trigeminal neuralgia. Most patients prefer the intranasal spray to trigeminal nerve block with a needle due to prompt analgesia without severe pain attendant on procedure. Further work is required to assess the proper concentration and volume of intranasal lidocaine in order to provide a better effect and at the same time less unfavorable adverse effects in patients with refractory trigeminal neuralgia. Akifumi Kanai Departmeny of Anesthesiology Kitasato University School of Medicine, Japan kanaiakifumi@aol.com Conflict of Interest:None declared |
|||
|
|
|||
|
Daniel W Wheeler University of Cambridge
Send letter to journal:
|
Editor – Kanai and colleagues are to be congratulated on their study of the efficacy of 8% lidocaine intranasal spray for treatment of paroxysmal second-division trigeminal neuralgia.[1] They showed that 0.2 ml 8% lidocaine applied to the sphenopalatine ganglion, which lies just posterior to the middle turbinate, provides effective pain relief for approximately four hours. They observed that 15 out of 25 subjects felt burning or stinging in the treated nostril, and commented that this made the study difficult to blind. Lee and colleagues recently described a means of inserting a laryngeal mask airway using topical anaesthesia with 10% lidocaine combined with a remifentanil infusion.[2] All the subjects experienced a sore throat afterwards. I experienced a very sore throat after topical anaesthesia with 10% lidocaine when participating in a fibreoptic intubation course. A fibreoptic intubation instructor I know believes the incidence of burning and stinging increases proportionately with lidocaine concentration, and avoids very concentrated lidocaine solutions for this reason despite the lack of published data on the matter. I appreciate that 8% lidocaine was chosen for this study to reduce the volume administered, as participants in other studies have reported an unpleasant taste and swallowing difficulties as a result of local anaesthetic applied to the nostril reaching the pharynx and larynx.[3,4] However, it would have been useful if Kanai and colleagues had communicated the proportion of patients continuing to use the 8% lidocaine spray after the study ended, providing a good indication as to the tolerability of the treatment and reassurance that it does not simply replace one pain with another. D. W. Wheeler, Cambridge, U.K. References 1. Kanai A, Suzuki A, Kobayashi M, Hoka S. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br J Anaesth 2006; 97: 559 -63 2. Lee MC, Absalom AR, Menon DK, Smith HL. Awake insertion of the laryngeal mask airway using topical lidocaine and intravenous remifentanil. Anaesthesia 2006; 61: 32-5 3. Sadek SA, De R, Scott A, White AP, Wilson PS, Carlin WV. The efficacy of topical anaesthesia in flexible nasendoscopy: a double-blind randomised controlled trial. Clin Otolaryngol Allied Sci 2001; 26: 25-8 4. Kudrow L, Kudrow DB, Sandweiss JH. Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings. Headache 1995; 35: 79-82 Conflict of Interest:None declared |
|||